Ceftolozane/tazobactam for pulmonary exacerbation in a 63-year-old cystic fibrosis patient with renal insufficiency and an elevated MIC to

Ceftolozane/tazobactam Cystic fibrosis Therapeutic drug monitoring

Journal

IDCases
ISSN: 2214-2509
Titre abrégé: IDCases
Pays: Netherlands
ID NLM: 101634540

Informations de publication

Date de publication:
2020
Historique:
received: 07 04 2020
revised: 07 05 2020
accepted: 14 05 2020
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 4 6 2020
Statut: epublish

Résumé

Cystic fibrosis (CF) is a progressive genetic disorder caused by mutations in a gene encoding the cystic fibrosis transmembrane regulator (CFTR) protein leading to persistent and difficult to treat lower airway infections. Multi-drug resistant

Identifiants

pubmed: 32489878
doi: 10.1016/j.idcr.2020.e00830
pii: S2214-2509(20)30138-4
pii: e00830
pmc: PMC7256659
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e00830

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

No conflicts of interest to disclose.

Références

J Antimicrob Chemother. 2015 Dec;70(12):3178-83
pubmed: 26188037
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6578-6584
pubmed: 27550351
J Chromatogr Sci. 2016 Jul;54(6):1037-40
pubmed: 27048639
Am J Health Syst Pharm. 2019 Apr 8;76(8):501-504
pubmed: 31361864
Antimicrob Agents Chemother. 2014 Sep;58(9):5350-7
pubmed: 24982069
J Antimicrob Chemother. 2020 Feb 1;75(2):429-433
pubmed: 31665353
Respir Med Case Rep. 2017 Oct 28;23:8-9
pubmed: 29159032
Lancet Infect Dis. 2019 Dec;19(12):1299-1311
pubmed: 31563344
Clin Pharmacokinet. 1998 Oct;35(4):313-29
pubmed: 9812180
Pediatr Pulmonol. 2002 Aug;34(2):91-100
pubmed: 12112774
Clin Ther. 2004 Apr;26(4):493-501
pubmed: 15189746
Lancet. 2015 May 16;385(9981):1949-56
pubmed: 25931244
Pharmacotherapy. 2004 Nov;24(11):1641-5
pubmed: 15537567
Drugs. 1988 May;35(5):542-78
pubmed: 3293970
Pharmacotherapy. 2016 Oct;36(10):e154-e159
pubmed: 27522066
J Cyst Fibros. 2016 Sep;15(5):660-3
pubmed: 27132188
N Engl J Med. 2005 May 12;352(19):1992-2001
pubmed: 15888700
Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51
pubmed: 14555458
Clin Microbiol Rev. 2019 Aug 28;32(4):
pubmed: 31462403

Auteurs

Meredith Tate Romano (MT)

Ascension Sacred Heart Hospital, Pensacola, FL, United States.

Sasha Premraj (S)

Ascension Sacred Heart Hospital, Pensacola, FL, United States.

John M Bray (JM)

Adult Cystic Fibrosis Center, Pensacola Lung Group, Pensacola, FL, United States.

Luis C Murillo (LC)

Adult Cystic Fibrosis Center, Pensacola Lung Group, Pensacola, FL, United States.

Classifications MeSH